A Case of Tumor Betrayal
Yan Li,Marsha A. Moses
DOI: https://doi.org/10.1016/s0002-9440(10)64067-9
2001-01-01
Abstract:Among a number of different proteinases that are capable of digesting extracellular matrix (ECM) components, the matrix metalloproteinases (MMPs), a family of zinc-dependent endopeptidases, play a major role.1Woessner F Nagase H Matrix Metalloproteinases and TIMPs. Oxford University Press, London2000Google Scholar Collectively, MMPs have been shown to cleave most ECM components either independently or in a collaborative manner. Because excessive digestion of ECM is a hallmark of many pathological conditions including tumor growth and metastasis, it is critical that MMP activity be precisely regulated both spatially and temporally. In addition to the transcriptional and translational control of MMP expression by growth hormones/factors, cytokines, cell-ECM or cell-cell contacts, and oncogene expression, MMP activity is regulated by their endogenous inhibitors, the tissue inhibitors of matrix metalloproteinases (TIMPs). TIMPs not only directly control the activity of active MMPs, but also have substantial influence on the activation process of MMP zymogens.2Murphy G Knauper V Relating matrix metalloproteinase structure to function: why the “hemopexin” domain?.Matrix Biol. 1997; 15: 511-518Crossref PubMed Scopus (260) Google Scholar, 3Nagase H Cell surface activation of progelatinase A (proMMP-2) and cell migration.Cell Res. 1998; 8: 179-186Crossref PubMed Scopus (173) Google Scholar, 4Goldberg GI Strongin A Collier IE Genrich LT Marmer BL Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.J Biol Chem. 1992; 267: 4583-4591Abstract Full Text PDF PubMed Google Scholar, 5Kurschat P Zigrino P Nischt R Breitkopf K Steurer P Klein CE Krieg T Mauch C Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines.J Biol Chem. 1999; 274: 21056-21062Crossref PubMed Scopus (148) Google ScholarGiven the ability of TIMPs to inhibit the proteolytic activity of MMPs, it is not surprising to find that TIMPs are capable of blocking tumor metastasis, either by inhibiting tumor invasion of basement membrane or by restraining tumor angiogenesis.6Gomez DE Alonso DF Yoshiji H Thorgeirsson UP Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.Eur J Cell Biol. 1997; 74: 111-122PubMed Google Scholar However, recent studies have suggested that the inhibitory effects of TIMPs on tumor progression are not only due to their ability to inhibit MMP activity, but also because of their ability to directly modulate the cell growth and apoptosis of tumor cells, as well as host endothelial cells (ECs).In an intriguing study published in this issue of The American Journal of Pathology, divergent effects of TIMP-1 on Burkitt’s lymphoma growth in nude mice are reported by Guedez and co-workers.96Guedez L McMarlin AJ Kingma DW Bennett TA Stetler-Stevenson M Stetler-Stevenson WG Tissue inhibitor of metalloproteinases (TIMP)-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.Am J Pathol. 2001; 158: 1207-1215Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar When Epstein-Barr virus-negative Burkitt’s lymphoma cells were forced to overexpress TIMP-1 by retroviral transfection, a biphasic tumor growth pattern was observed. After injection into nude mice, these cells showed an initial fast proliferation phase due to the stimulation of tumor cell proliferation and the protection from apoptosis elicited by TIMP-1. However, once these tumors reached a certain size (0.4 mm2), the initial fast growth phase was replaced by a slowdown of tumor progression accompanied by tumor necrosis and regression. The authors provide convincing evidence to show that this late stage inhibition was caused by the suppression of tumor-induced host angiogenesis. These novel in vivo results highlight the importance of MMPs and their endogenous inhibitors during tumor progression and angiogenesis.TIMPs and Tumor GrowthTIMPs and Cell ProliferationSince first being discovered as having the ability to stimulate the proliferation of erythroid progenitor cells,7Gasson JC Golde DW Kaufman SE Westbrook CA Hewick RM Kaufman RJ Wong GG Temple PA Leary AC Brown EL Orr EC Clark SC Molecular characterization and expression of the gene encoding human erythroid-potentiating activity.Nature. 1985; 315: 768-771Crossref PubMed Scopus (214) Google Scholar in addition to inhibiting MMP activity,8Docherty AJ Lyons A Smith BJ Wright EM Stephens PE Harris TJ Murphy G Reynolds JJ Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity.Nature. 1985; 318: 66-69Crossref PubMed Scopus (582) Google Scholar TIMP-1’s growth promoting effects have been extended to a variety of cells, including mammary epithelial cells,9Fata JE Leco KJ Moorehead RA Martin DC Khokha R Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development.Dev Biol. 1999; 211: 238-254Crossref PubMed Scopus (91) Google Scholar keratinocytes,10Bertaux B Hornebeck W Eisen AZ Dubertret L Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases.J Invest Dermatol. 1991; 97: 679-685Abstract Full Text PDF PubMed Google Scholar lymphoid, myeloid, endothelial, fibroblasts, hepatoma, breast carcinoma, and chondrocyte cells.11Hayakawa T Yamashita K Tanzawa K Uchijima E Iwata K Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.FEBS Lett. 1992; 298: 29-32Crossref PubMed Scopus (645) Google Scholar Like TIMP-1, TIMP-2 was shown to stimulate cell proliferation in human osteosarcoma cells and cultured rabbit corneal epithelial cells, potentially via a tyrosine kinase-dependent signaling pathway,12Yamashita K Suzuki M Iwata H Koike T Hamaguchi M Shinagawa A Noguchi T Hayakawa T Tyrosine phosphorylation is crucial for growth signaling by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2).FEBS Lett. 1996; 396: 103-107Abstract Full Text PDF PubMed Scopus (87) Google Scholar, 13Saika S Kawashima Y Okada Y Tanaka SI Yamanaka O Ohnishi Y Ooshima A Recombinant TIMP-1 and -2 enhance the proliferation of rabbit corneal epithelial cells in vitro and the spreading of rabbit corneal epithelium in situ.Curr Eye Res. 1998; 17: 47-52Crossref PubMed Scopus (31) Google Scholar and to promote fibroblast or fibrosarcoma cell growth by stimulating cAMP production.14Corcoran ML Stetler-Stevenson WG Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism.J Biol Chem. 1995; 270: 13453-13459Crossref PubMed Scopus (165) Google Scholar Unlike TIMP-1,11Hayakawa T Yamashita K Tanzawa K Uchijima E Iwata K Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.FEBS Lett. 1992; 298: 29-32Crossref PubMed Scopus (645) Google Scholar TIMP-2 also exhibits inhibitory effects on the proliferation of ECs,15Murphy AN Unsworth EJ Stetler-Stevenson WG Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.J Cell Physiol. 1993; 157: 351-358Crossref PubMed Scopus (312) Google Scholar renal carcinoma cells,16Miyake H Hara I Gohji K Yamanaka K Hara S Arakawa S Nakajima M Kamidono S Relative expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in mouse renal cell carcinoma cells regulates their metastatic potential.Clin Cancer Res. 1999; 5: 2824-2829PubMed Google Scholar and several other carcinoma cells.17Hoegy SE Oh HR Corcoran ML Stetler-Stevenson WG Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition.J Biol Chem. 2000; 276: 3222-3230PubMed Google Scholar Interestingly, TIMP-1 and TIMP-2 exert different effects on EC processes in that TIMP-2 inhibits fibroblast growth factor-driven EC proliferation and TIMP-1 does not.15Murphy AN Unsworth EJ Stetler-Stevenson WG Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.J Cell Physiol. 1993; 157: 351-358Crossref PubMed Scopus (312) Google Scholar In fact, the latter has been shown to exert a stimulatory effect on EC growth in vitro.11Hayakawa T Yamashita K Tanzawa K Uchijima E Iwata K Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.FEBS Lett. 1992; 298: 29-32Crossref PubMed Scopus (645) Google Scholar Both inhibitors can, however, suppress capillary EC migration and tube formation in response to angiogenic stimuli.18Moses MA The regulation of neovascularization of matrix metalloproteinases and their inhibitors.Stem Cells. 1997; 15: 180-189Crossref PubMed Scopus (260) Google ScholarThese regulatory effects of TIMPs on cell proliferation may not necessarily be a function of their MMP inhibitory activity.15Murphy AN Unsworth EJ Stetler-Stevenson WG Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.J Cell Physiol. 1993; 157: 351-358Crossref PubMed Scopus (312) Google Scholar, 19Chesler L Golde DW Bersch N Johnson MD Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1.Blood. 1995; 86: 4506-4515Crossref PubMed Google Scholar For example, modulation of cell proliferation by TIMPs has been attributed to their interactions with unknown cell surface receptors,10Bertaux B Hornebeck W Eisen AZ Dubertret L Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases.J Invest Dermatol. 1991; 97: 679-685Abstract Full Text PDF PubMed Google Scholar, 14Corcoran ML Stetler-Stevenson WG Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism.J Biol Chem. 1995; 270: 13453-13459Crossref PubMed Scopus (165) Google Scholar as well as to their potential regulation of DNA synthesis in the nucleus.20Ritter LM Garfield SH Thorgeirsson UP Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells.Biochem Biophys Res Commun. 1999; 257: 494-499Crossref PubMed Scopus (89) Google Scholar, 21Zhao WQ Li H Yamashita K Guo XK Hoshino T Yoshida S Shinya T Hayakawa T Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts.J Cell Sci. 1998; 111: 1147-1153PubMed Google Scholar Moreover, the divergent and sometimes even contradictory effects of TIMPs on cell growth in vitro are cell type-specific. Although these provocative findings could be taken to presage the divergent effects of tumor growth and angiogenesis that is demonstrated by Guedez and co-workers,96Guedez L McMarlin AJ Kingma DW Bennett TA Stetler-Stevenson M Stetler-Stevenson WG Tissue inhibitor of metalloproteinases (TIMP)-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.Am J Pathol. 2001; 158: 1207-1215Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar their study is the first to document these two divergent in vivo effects within the same tumor system. It will be important to learn whether this biphasic effect is observed in other tumor systems and whether all TIMPs are capable of exerting this same effect.TIMPs and Tumor Cell ApoptosisIn addition to their growth-promoting ability, TIMPs can also affect programmed cell death, or apoptosis, in both normal cells and transformed tumor cells. TIMP-1 expression levels have been shown to correlate with cell apoptosis in a series of B lymphoma cells.22Guedez L Stetler-Stevenson WG Wolff L Wang J Fukushima P Mansoor A Stetler-Stevenson M In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.J Clin Invest. 1998; 102: 2002-2010Crossref PubMed Scopus (361) Google Scholar, 23Guedez L Courtemanch L Stetler-Stevenson M Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells.Blood. 1998; 92: 1342-1349Crossref PubMed Google Scholar Overexpression of TIMP-1 can rescue mammary epithelial cells from apoptosis induced by uncontrolled ECM degradation.24Alexander CM Howard EW Bissell MJ Werb Z Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene.J Cell Biol. 1996; 135: 1669-1677Crossref PubMed Scopus (203) Google Scholar Similarly, TIMP-2 expression has inhibitory effects on apoptosis of melanoma cells.25Valente P Fassina G Melchiori A Masiello L Cilli M Vacca A Onisto M Santi L Stetler-Stevenson WG Albini A TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis [published erratum appears in Int J Cancer 1999, 80: 485].Int J Cancer. 1998; 75: 246-253Crossref PubMed Scopus (250) Google Scholar In contrast, however, it has been reported that TIMP-3, a matrix-associated inhibitor, induces cell apoptosis in melanoma cells,26Ahonen M Baker AH Kahari VM Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.Cancer Res. 1998; 58: 2310-2315PubMed Google Scholar colon carcinoma cells,27Smith MR Kung H Durum SK Colburn NH Sun Y TIMP-3 induces cell death by stabilizing TNF-α receptors on the surface of human colon carcinoma cells.Cytokine. 1997; 9: 770-780Crossref PubMed Scopus (175) Google Scholar and vascular smooth muscle cells.28Baker AH Zaltsman AB George SJ Newby AC Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis.J Clin Invest. 1998; 101: 1478-1487Crossref PubMed Scopus (414) Google Scholar The cell-death domain of TIMP-3 has been localized to the amino terminus and its apoptotic effect appears to correlate with the inhibition of metalloproteinase activity.29Bond M Murphy G Bennett MR Amour A Knauper V Newby AC Baker AH Localization of the death domain of tissue inhibitor of metalloproteinase-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptotic activity.J Biol Chem. 2000; 275: 41358-41363Crossref PubMed Scopus (105) Google ScholarAccording to Guedez and colleagues,96Guedez L McMarlin AJ Kingma DW Bennett TA Stetler-Stevenson M Stetler-Stevenson WG Tissue inhibitor of metalloproteinases (TIMP)-1 alters the tumorigenicity of Burkitt's lymphoma via divergent effects on tumor growth and angiogenesis.Am J Pathol. 2001; 158: 1207-1215Abstract Full Text Full Text PDF PubMed Scopus (96) Google Scholar the initial growth-stimulatory effect of TIMP-1 on Burkitt’s lymphoma in vivo is likely achieved through its inhibition of apoptosis. In fact, the same group has recently reported that TIMP-1 expression in Burkitt’s lymphoma cell lines inhibits induction of apoptosis by Fas-dependent and -independent pathways, and up-regulates BCL-XL expression.22Guedez L Stetler-Stevenson WG Wolff L Wang J Fukushima P Mansoor A Stetler-Stevenson M In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.J Clin Invest. 1998; 102: 2002-2010Crossref PubMed Scopus (361) Google Scholar Based simply on the anti-apoptotic effect of TIMP-1, one would expect that TIMP-1-positive tumors would grow much more aggressively than their TIMP-1-negative counterparts. However in this study, after reaching a certain size (0.4 mm2), the growth rate of TIMP-1-positive tumors decreased significantly. These observations led the authors to invoke the anti-angiogenic activity of TIMP-1 as a potential mechanism for the tumor suppression observed in their model. This anti-angiogenic mechanism is strongly supported by the immunostaining and microvessel counts provided in this study. In addition, their finding that tumor regression after the initial period of increased tumor growth was marked by the presence of only microscopic foci of residual proliferating tumor cells observed only on biopsy of the tumor site is reminiscent of the tumor dormancy elicited by a number of angiogenesis inhibitors30Holmgren L Jackson G Arbiser J p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma.Oncogene. 1998; 17: 819-824Crossref PubMed Scopus (46) Google Scholar, 31O'Reilly MS Holmgren L Shing Y Chen C Rosenthal RA Moses M Lane WS Cao Y Sage EH Folkman J Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [see comments].Cell. 1994; 79: 315-328Abstract Full Text PDF PubMed Scopus (3150) Google Scholar, 32O'Reilly MS Boehm T Shing Y Fukai N Vasios G Lane WS Flynn E Birkhead JR Olsen BR Folkman J Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell. 1997; 88: 277-285Abstract Full Text Full Text PDF PubMed Scopus (4212) Google Scholar and begs the question as to how long this dormant period might last. Based on recent work demonstrating that MMPs may be required for the acquisition of the angiogenic phenotype during tumor progression,33Fang J Shing Y Wiederschain D Yan L Butterfield C Jackson G Harper J Tamvakopoulos G Moses MA Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.Proc Natl Acad Sci USA. 2000; 97: 3884-3889Crossref PubMed Scopus (344) Google Scholar, 34Bergers G Brekken R McMahon G Vu TH Itoh T Tamaki K Tanzawa K Thorpe P Itohara S Werb Z Hanahan D Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.Nat Cell Biol. 2000; 2: 737-744Crossref PubMed Scopus (2251) Google Scholar we would hypothesize that any shift in the proteolytic balance in favor of MMP activity would activate the switch to the angiogenic phenotype, thereby bringing an end to the period of tumor dormancy.TIMPs and Tumor MetastasisThe inhibitory function of TIMPs during tumor metastasis has been well demonstrated in a variety of tumors. Overexpression of TIMP-1 or TIMP-2 inhibits the invasive behavior of highly invasive and metastatic B16F10 murine melanoma cells,25Valente P Fassina G Melchiori A Masiello L Cilli M Vacca A Onisto M Santi L Stetler-Stevenson WG Albini A TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis [published erratum appears in Int J Cancer 1999, 80: 485].Int J Cancer. 1998; 75: 246-253Crossref PubMed Scopus (250) Google Scholar fibrosarcoma cells,35Tanaka K Iwamoto Y Ito Y Ishibashi T Nakabeppu Y Sekiguchi M Sugioka Y Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080.Cancer Res. 1995; 55: 2927-2935PubMed Google Scholar the osteolytic bone metastases of breast carcinoma,36Yoneda T Sasaki A Dunstan C Williams PJ Bauss F De Clerck YA Mundy GR Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.J Clin Invest. 1997; 99: 2509-2517Crossref PubMed Scopus (226) Google Scholar and the extravasation of pulmonary metastasis of a bladder carcinoma.37Kawamata H Kawai K Kameyama S Johnson MD Stetler-Stevenson WG Oyasu R Over-expression of tissue inhibitor of matrix metalloproteinases (TIMP1 and TIMP2) suppresses extravasation of pulmonary metastasis of a rat bladder carcinoma.Int J Cancer. 1995; 63: 680-687Crossref PubMed Scopus (66) Google Scholar The newly identified TIMP-4 has also been shown to inhibit breast carcinoma cell invasion in vitro and tumor metastasis in vivo.38Wang M Liu YE Greene J Sheng S Fuchs A Rosen EM Shi YE Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.Oncogene. 1997; 14: 2767-2774Crossref PubMed Scopus (146) Google Scholar Furthermore, targeted disruption of TIMP-1 expression increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells.39Alexander CM Werb Z Targeted disruption of the tissue inhibitor of metalloproteinases gene increases the invasive behavior of primitive mesenchymal cells derived from embryonic stem cells in vitro.J Cell Biol. 1992; 118: 727-739Crossref PubMed Scopus (105) Google Scholar Adenovirus-mediated expression of TIMP-3 resulted in a similar, and even more potent, inhibition of cell invasion than that caused by TIMP-1 and TIMP-2, in melanoma, fibrosarcoma, and ovarian carcinoma cells.26Ahonen M Baker AH Kahari VM Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.Cancer Res. 1998; 58: 2310-2315PubMed Google Scholar, 40Baker AH George SJ Zaltsman AB Murphy G Newby AC Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.Br J Cancer. 1999; 79: 1347-1355Crossref PubMed Scopus (246) Google Scholar In addition, TIMP-3 can also induce apoptosis by preventing cell adhesion to underlying matrix.26Ahonen M Baker AH Kahari VM Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells.Cancer Res. 1998; 58: 2310-2315PubMed Google ScholarTIMPs and Tumor AngiogenesisTumor angiogenesis is required for sustained tumor growth because the new capillaries are conduits for oxygen and nutrients. Without angiogenesis, tumor growth is restricted to the tissue diffusion distance of ∼0.2 mm.41Folkman J Angiogenesis in cancer, vascular, rheumatoid and other disease.Nat Med. 1995; 1: 27-31Crossref PubMed Scopus (7177) Google Scholar MMPs and TIMPs have been shown to be involved in various stages of the angiogenic process, from EC migration and proliferation, to deposition and remodeling of basement membrane of newly formed blood vessels.18Moses MA The regulation of neovascularization of matrix metalloproteinases and their inhibitors.Stem Cells. 1997; 15: 180-189Crossref PubMed Scopus (260) Google Scholar Furthermore, modulation of MMP or TIMP expression has a profound influence on angiogenesis at various stages in different tumors.33Fang J Shing Y Wiederschain D Yan L Butterfield C Jackson G Harper J Tamvakopoulos G Moses MA Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model.Proc Natl Acad Sci USA. 2000; 97: 3884-3889Crossref PubMed Scopus (344) Google Scholar, 34Bergers G Brekken R McMahon G Vu TH Itoh T Tamaki K Tanzawa K Thorpe P Itohara S Werb Z Hanahan D Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis.Nat Cell Biol. 2000; 2: 737-744Crossref PubMed Scopus (2251) Google Scholar, 42Vu TH Shipley JM Bergers G Berger JE Helms JA Hanahan D Shapiro SD Senior RM Werb Z MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes.Cell. 1998; 93: 411-422Abstract Full Text Full Text PDF PubMed Scopus (1484) Google Scholar, 43Itoh T Tanioka M Yoshida H Yoshioka T Nishimoto H Itohara S Reduced angiogenesis and tumor progression in gelatinase A-deficient mice.Cancer Res. 1998; 58: 1048-1051PubMed Google Scholar, 44Martin DC Sanchez-Sweatman OH Ho AT Inderdeo DS Tsao MS Khokha R Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis.Lab Invest. 1999; 79: 225-234PubMed Google ScholarTIMPs and EC Proliferation and MigrationIt is only in recent years that the notion that certain TIMPs might be capable of exerting a pleiotropic effect on tumor growth, metastasis, and angiogenesis has come to be appreciated. Since the first report that a TIMP could inhibit angiogenesis in vitro and tumor angiogenesis in vivo,45Moses MA Sudhalter J Langer R Identification of an inhibitor of neovascularization from cartilage.Science. 1990; 248: 1408-1410Crossref PubMed Scopus (419) Google Scholar, 46Moses MA Langer R Inhibitors of angiogenesis.Biotechnology. 1991; 9: 630-634Crossref PubMed Scopus (83) Google Scholar a series of studies using a variety of endogenous MMP inhibitors have supported this suppression of neovascularization.15Murphy AN Unsworth EJ Stetler-Stevenson WG Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.J Cell Physiol. 1993; 157: 351-358Crossref PubMed Scopus (312) Google Scholar, 47Johnson MD Kim HR Chesler L Tsao-Wu G Bouck N Polverini PJ Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.J Cell Physiol. 1994; 160: 194-202Crossref PubMed Scopus (266) Google Scholar, 48Anand-Apte B Pepper MS Voest E Montesano R Olsen B Murphy G Apte SS Zetter B Inhibition of angiogenesis by tissue inhibitor of metalloproteinase-3 [see comments].Invest Ophthalmol Vis Sci. 1997; 38: 817-823PubMed Google Scholar At the time, the potential mechanisms of action focused on the ability of TIMPs to suppress mitogen-driven angiogenic events such as capillary EC proliferation, migration, and capillary tube and sprout formation. However, it was also reported that select TIMPs might also exert a stimulatory effect on EC functions required for successful angiogenesis. For example, TIMP-1 unlike TIMP-2, did not inhibit capillary EC proliferation15Murphy AN Unsworth EJ Stetler-Stevenson WG Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation.J Cell Physiol. 1993; 157: 351-358Crossref PubMed Scopus (312) Google Scholar but rather was reported to stimulate it.11Hayakawa T Yamashita K Tanzawa K Uchijima E Iwata K Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum.FEBS Lett. 1992; 298: 29-32Crossref PubMed Scopus (645) Google ScholarThe inhibitory effects of TIMPs on EC migration have been shown both in vitro and in vivo.25Valente P Fassina G Melchiori A Masiello L Cilli M Vacca A Onisto M Santi L Stetler-Stevenson WG Albini A TIMP-2 over-expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis [published erratum appears in Int J Cancer 1999, 80: 485].Int J Cancer. 1998; 75: 246-253Crossref PubMed Scopus (250) Google Scholar, 45Moses MA Sudhalter J Langer R Identification of an inhibitor of neovascularization from cartilage.Science. 1990; 248: 1408-1410Crossref PubMed Scopus (419) Google Scholar, 47Johnson MD Kim HR Chesler L Tsao-Wu G Bouck N Polverini PJ Inhibition of angiogenesis by tissue inhibitor of metalloproteinase.J Cell Physiol. 1994; 160: 194-202Crossref PubMed Scopus (266) Google Scholar, 49Fernandez HA Kallenbach K Seghezzi G Grossi E Colvin S Schneider R Mignatti P Galloway A Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1.J Surg Res. 1999; 82: 156-162Abstract Full Text PDF PubMed Scopus (59) Google Scholar Given the critical role of EC migration during angiogenesis,50Klagsbrun M Moses MA Molecular angiogenesis.Chem Biol. 1999; 6: R217-R224Abstract Full Text PDF PubMed Scopus (236) Google Scholar this inhibition may account, at least in part, for the reduced tumor angiogenesis observed in TIMP-1-positive lymphoma tumor implants in vivo.MMPs and TIMPs: Regulators of Angiogenic SignalsThe process of tumor angiogenesis is governed by a complex signaling network.50Klagsbrun M Moses MA Molecular angiogenesis.Chem Biol. 1999; 6: R217-R224Abstract Full Text PDF PubMed Scopus (236) Google Scholar The establishment of the neovasculature is modulated by soluble growth factors, hormones, and cytokines,51Hanahan D Folkman J Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis.Cell. 1996; 86: 353-364Abstract Full Text Full Text PDF PubMed Scopus (6018) Google Scholar as well as by insoluble ECM that underlies the participating vessels.52Ingber DE Folkman J How does extracellular matrix control capillary morphogenesis?.Cell. 1989; 58: 803-805Abstract Full Text PDF PubMed Scopus (381) Google Scholar, 53Ingber DE Extracellular matrix as a solid-state regulator in angiogenesis: identification of new targets for anti-cancer therapy.Semin Cancer Biol. 1992; 3: 57-63PubMed Google Scholar Metalloproteinases, together with TIMPs, have been shown to play pivotal roles during the angiogenic process, from processing latent growth factors and shedding receptors, to maintaining and remodeling EC basement membrane.18Moses MA The regulation of neovascularization of matrix metalloproteinases and their inhibitors.Stem Cells. 1997; 15: 180-189Crossref PubMed Scopus (260) Google Scholar These roles are discussed briefly here.Bioavailability of Soluble FactorsMany growth factors involved in angiogenesis reside in the ECM, associated with either their endogenous inhibitors or extracellular proteoglycans.54Taipale J Keski-Oja J Growth factors in the extracellular matrix.FASEB J. 1997; 11: 51-59Crossref PubMed Scopus (752) Google Scholar Therefore, to actively participate in angiogenesis, these sequestered growth factors must be released from their ECM compartments. A recent study has demonstrated that MMP-9 can liberate vascular endothelial growth factor from its ECM storage in a mouse pancreatic-islet carcinoma model.34Bergers G Brekken R McMahon G Vu TH Itoh T Tamaki K Tanzawa K Thorpe P Itohara S Werb Z Hanahan D Matr